Contrast Media/Contrast Agents Market By Product (Iodinated, Gadolinium & Barium), By Technique (X-ray, CT, MRI, Cath Lab & Ultrasound) & By Application (Radiology, Interventional Radiology & Interventional Cardiology) - Global Trends & Forecast to 2017


January 1, 2013
286 Pages - SKU: MKMK4939877
License type:
Table of Contents Search inside this report Related Reports Detailed Contents
Countries covered: Global

Contrast agents have evolved significantly over the past century, from barium and iodine-based agents that were used initially by medical practitioners and radiologists, to the more advanced agents like radiopharmaceuticals and gold nanoparticles that are currently in use. Sophisticated techniques such as targeted MRI imaging and gas microbubble technology in ultrasound will prove to be essential drivers in the widespread use of contrast agents in the future.

The global contrast media market is broadly segmented into barium-based, iodinated and gadolinium-based contrast media. These products are further categorized based on the medical procedure (X-ray, CT, MRI, ultrasound, and catheterization laboratory), route of administration (oral, injection, rectal, and urethral), medical indication (cardiovascular, respiratory, musculoskeletal, gastrointestinal, and neurology, nephrology and oncology) and finally application (radiology, interventional radiology and interventional cardiology). The global contrast media market is worth $6.2 billion in 2012, and estimated to grow at a CAGR of 6.8% to reach $8.6 billion by 2017.

The global contrast media market, though fairly mature at present (2012), still shows potential to grow over the next five years. It is propelled by the increasing demand for diagnostic imaging and image guided surgical procedures, technological advances in diagnostic imaging and the ever-increasing incidence rates of cancer and cardiac disorders. However, a few pivotal factors affecting the growth of this market are major economies of the world undergoing healthcare reforms, thereby affecting contrast media sales and the economic slowdown restricting the overall growth of this market.

The U.S. represents the largest contrast media market worldwide, followed by Europe and Japan. However, the economic slowdown has augmented opportunities for emerging markets like India and China to strengthen their position in the global arena. Advances in medical technology coupled with huge foreign investments from developed nations, allows these emerging markets to compete with global market leaders in this segment. Investment firms are increasingly focusing on expansion in developing markets of Asia, Latin America and Eastern Europe, since the U.S. is on the brink of embracing healthcare reforms and major economies in Europe are still recovering from huge financial deficits.

The global marketplace is highly competitive, with several small players specific to a particular geography challenging major ones. Owing to the recession and the emerging opportunities in developing countries, many small companies have similar product offerings at competitive prices. Some of the major players profiled in this report are GE Healthcare (U.K.), Bracco Diagnostic, Inc. (Italy), Bayer Healthcare Pharmaceuticals (Germany), Covidien (Ireland) and Guerbet Group (France).

The scope of the report spans the global contrast media market which comprises:

Global Contrast Media Market, by Product

Barium-based contrast media
Iodinated contrast media
Low-osmolar contrast media (LOCM)
High-osmolar contrast media (HOCM)
Gadolinium-based contrast media
Global Contrast Media Market, by Route of Administration

Oral
Injection
Intravenous (I.V.)
Intra-arterial (I.A.)
Rectal
Urethral
Global Contrast Media Market, by Medical Procedure

X-ray
Computed tomography (CT)
Magnetic resonance imaging (MRI)
Ultrasound
Catheterization laboratory (cath lab)
Global Contrast Media Market, by Indication

Cardiovascular disorders
Neurological disorders
Gastrointestinal disorders
Respiratory diseases
Musculoskeletal anomalies
Nephrological disorders
Oncology (tumor detection)
Global Contrast Media Market, by Application

Radiology
Interventional radiology
Interventional cardiology
Contrast Media Market, by Geography

North America
U.S.
Canada
Europe
United Kingdom (U.K.)
Germany
France
Italy
Spain
Scandinavian countries (Sweden, Denmark, Finland, and Norway)
Rest of Europe
Asia-Pacific (APAC)
Japan
China
India
Rest of Asia-Pacific
Rest of the world (RoW)
Latin America
Middle East & Africa
Russia

Each section of the report offers market data for the various market segments and geographies. It also provides in-depth information on market trends with respect to drivers, restraints, opportunities and technology trends.


1 Introduction
1.1 Key Take-aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Executive Summary
3 Market Overview
3.1 Introduction
3.2 Market Segmentation
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Increasing Demand For Diagnostic & Image Guided Procedures Influences Contrast Media Sales
3.3.1.2 Technological Advancements To Spur The Contrast Media Market
3.3.1.3 Increasing Incidence & Mortality Of Cancer & Cardiac Diseases To Boost Growth Of Contrast Media
3.3.1.4 Growth Of Medical Imaging Technology In Emerging Markets
3.3.2 Restraints
3.3.2.1 Major Economies Undergoing Healthcare Reforms To Affect The Sales On Contrast Media
3.3.2.2 Economic Slowdown To Inhibit Growth
3.3.3 Opportunities
3.3.3.1 Growing Investment Potential In Immature Emerging Markets
3.3.3.2 Advent Of Novel Contrast Agents Combining Properties Of Contrast Media & Radiopharmaceuticals
3.3.4 Burning Issue - Toxicity
3.3.4.1 Nephrogenic Systemic Fibrosis (Nsf)
3.3.4.2 Contrast-induced Nephrotoxicity (Cin)
3.3.5 Technology Trends
3.3.5.1 N1177 – A Revolutionary Macrophage Labeling Agent
3.3.5.2 Spago Pix – Accurate Visualization Of Tumors With Mri
3.3.5.3 Cmc-001 – Focused On Liver Mri
3.4 Market Share Analysis
4 Global Contrast Media Market, By Product
4.1 Introduction
4.2 Barium-based Contrast Media
4.2.1 Technical Overview
4.2.2 Market Dynamics
4.2.3 Market Analysis
4.3 Iodinated Contrast Media
4.3.1 Technical Overview
4.3.2 Market Dynamics
4.3.3 Market Analysis
4.3.4 Types – Low-osmolar And High-osmolar
4.3.4.1 Low-osmolar Contrast Media (Locm)
4.3.4.1.1 Technical Overview
4.3.4.1.2 Market Analysis
4.3.4.2 High-osmolar Contrast Media (Hocm)
4.3.4.2.1 Technical Overview
4.3.4.2.2 Market Analysis
4.4 Gadolinium-based Contrast Media
4.4.1 Technical Overview
4.4.2 Market Dynamics
4.4.3 Market Analysis
5 Global Contrast Media Market, By Route Of Administration
5.1 Introduction
5.2 Oral Contrast Media
5.2.1 Technical Overview
5.2.2 Market Dynamics
5.2.3 Market Analysis
5.3 Injectable Contrast Media
5.3.1 Technical Overview
5.3.2 Market Dynamics
5.3.3 Market Analysis
5.3.4 Injectable Contrast Media – Types
5.3.4.1 Intravenous (Iv)
5.3.4.2 Intra-arterial (Ia)
5.4 Rectal Contrast Media
5.4.1 Technical Overview
5.4.2 Market Dynamics
5.4.3 Market Analysis
5.5 Urethral Contrast Media
5.5.1 Technical Overview
5.5.2 Market Dynamics
5.5.3 Market Analysis
6 Global Contrast Media Market, By Medical Procedure
6.1 Introduction
6.2 X-ray
6.2.1 Technical Overview
6.2.2 Market Dynamics
6.2.3 Market Analysis
6.3 Computed Tomography (Ct)
6.3.1 Technical Overview
6.3.2 Market Dynamics
6.3.3 Market Analysis
6.4 Magnetic Resonance Imaging (Mri)
6.4.1 Technical Overview
6.4.2 Market Dynamics
6.4.3 Market Analysis
6.5 Ultrasound
6.5.1 Technical Overview
6.5.2 Market Dynamics
6.5.3 Market Analysis
6.6 Catheterization Laboratory (Cath Lab)
6.6.1 Technical Overview
6.6.2 Market Dynamics
6.6.3 Market Analysis
7 Global Contrast Media Market, By Indication
7.1 Introduction
7.2 Cardiovascular Disorders
7.2.1 Market Dynamics
7.2.2 Market Analysis
7.3 Neurological Disorders
7.3.1 Market Dynamics
7.3.2 Market Analysis
7.4 Respiratory Diseases
7.4.1 Market Dynamics
7.4.2 Market Analysis
7.5 Gastrointestinal Disorders
7.5.1 Market Dynamics
7.5.2 Market Analysis
7.6 Oncology
7.6.1 Market Dynamics
7.6.2 Market Analysis
7.7 Musculoskeletal Anomalies
7.7.1 Market Dynamics
7.7.2 Market Analysis
7.8 Nephrological Disorders
7.8.1 Market Dynamics
7.8.2 Market Analysis
8 Global Contrast Media Market, By Application
8.1 Introduction
8.2 Radiology
8.2.1 Technical Overview
8.2.2 Market Dynamics
8.2.3 Market Analysis
8.3 Interventional Radiology
8.3.1 Technical Overview
8.3.2 Market Dynamics
8.3.3 Market Analysis
8.4 Interventional Cardiology
8.4.1 Technical Overview
8.4.2 Market Dynamics
8.4.3 Market Analysis
9 Geographic Analysis
9.1 Introduction
9.2 North America
9.3 Europe
9.4 Asia-pacific
9.5 Rest Of The World (Row)
10 Competitive Landscape
10.1 Introduction
10.2 Mergers & Acquisitions
10.3 Agreements, Partnerships, Collaborations & Joint Ventures
10.4 New Product Launch
10.5 Expansion
10.6 Approvals
10.7 Other Developments
11 Company Profiles (Overview, Financials, Products & Services, Strategy, And Developments)*
Snapshot
11.1 Amag Pharmaceuticals, Inc.
11.2 Bayer Healthcare Pharmaceuticals
11.3 Bracco Imaging Spa (A Subsidiary Of Bracco S.P.A)
11.4 Covidien
11.5 Cmc Contrast Ab
11.6 Daiichi Sankyo Co., Ltd.
11.7 Ge Healthcare
11.8 Genovis Ab
11.9 Guerbet Group
11.10 Lantheus Medical Imaging, Inc.
11.11 Nanopet Pharma Gmbh
11.12 Nanoscan Imaging, Llc
11.13 Sanochemia Pharmazeutika Ag
11.14 Spago Imaging Ab (A Subsidiary Of Accelerator Nordic Ab)
11.15 Subhra Pharma Private, Ltd
11.16 Taejoon Pharm Co., Ltd.
11.17 Targeson, Inc.
11.18 Unijules Life Sciences, Ltd.
*Details On Financials, Product & Services, Strategy, And Developments Might Not Be Captured In Case Of Unlisted Companies.
List Of Tables
Table 1 Global Contrast Media Market, By Product,
2010 – 2017 ($million)
Table 2 Contrast Media Market, By Geography, 2010 – 2017 ($million)
Table 3 Classification Of Gbcas By U.S. Fda Based On Number Of Nsf Cases
Table 4 Global Contrast Media Market Revenue, By Product,
2010 - 2017 ($million)
Table 5 Global Contrast Media Market Revenue, By Geography,
2010 – 2017 ($million)
Table 6 Barium-based Contrast Media Market Revenue, By Geography, 2010-2017 ($million)
Table 7 Iodinated Contrast Media Market Revenue, By Geography, 2010 – 2017 ($million)
Table 8 Iodinated Contrast Media Market Revenue, By Type,
2010 - 2017 ($million)
Table 9 Iodinated-locm Contrast Media Market Revenue,
By Geography, 2010 – 2017 ($million)
Table 10 Iodinated-hocm Contrast Media Market Revenue,
By Geography, 2010 – 2017 ($million)
Table 11 Gadolinium-based Contrast Media Market Revenue,
By Geography, 2010 - 2017 ($million)
Table 12 Global Contrast Media Market Revenue, By Route Of Administration, 2010 – 2017 ($million)
Table 13 Oral Contrast Media Market Revenue, By Geography,
2010 – 2017 ($million)
Table 14 Injectable Contrast Media Market Revenue, By Geography, 2010 – 2017 ($million)
Table 15 Injectable Contrast Media Market Revenue, By Type,
2010 – 2017 ($million)
Table 16 Intravenous Injectable Contrast Media Market Revenue,
By Geography, 2010 – 2017 ($million)
Table 17 Intra-arterial Injectable Contrast Media Market Revenue,
By Geography, 2010 – 2017 ($million)
Table 18 Rectal Contrast Media Market Revenue, By Geography,
2010 – 2017 ($million)
Table 19 Urethral Contrast Media Market Revenue, By Geography,
2010 – 2017 ($million)
Table 20 Global Contrast Media Market Revenue, By Medical Procedure, 2010 – 2017 ($million)
Table 21 X-ray Contrast Media Market Revenue, By Geography,
2010 – 2017 ($million)
Table 22 Ct Contrast Media Market Revenue, By Geography,
2010 – 2017 ($million)
Table 23 Mri Contrast Media Market Revenue, By Geography,
2010 – 2017 ($million)
Table 24 Ultrasound Contrast Media Market Revenue, By Geography, 2010 – 2017 ($million)
Table 25 Cath Lab Contrast Media Market Revenue, By Geography,
2010 – 2017 ($million)
Table 26 Global Contrast Media Market, By Indication,
2010 – 2017 ($million)
Table 27 Cardiovascular Diseases - Contrast Media Market,
By Geography, 2010 – 2017 ($million)
Table 28 Neurological Disorders - Contrast Media Market,
By Geography, 2010 – 2017 ($million)
Table 29 Respiratory Diseases - Contrast Media Market Revenue,
By Geography, 2010 – 2017 ($million)
Table 30 Gastrointestinal Disorders - Contrast Media Market,
By Geography, 2010 – 2017 ($million)
Table 31 Oncology - Contrast Media Market, By Geography,
2010 – 2017 ($million)
Table 32 Musculoskeletal Anomalies – Contrast Media Market,
By Geography, 2010 – 2017 ($million)
Table 33 Nephrological Disorders - Contrast Media Market Revenue, By Geography, 2010 – 2017 ($million)
Table 34 Global Contrast Media Market Revenue, By Application,
2010 – 2017 ($million)
Table 35 Radiology Contrast Media Market Revenue, By Geography, 2010 – 2017 ($million)
Table 36 Interventional Radiology Contrast Media Market Revenue,
By Geography, 2010 – 2017 ($million)
Table 37 Interventional Cardiology Contrast Media Market Revenue, By Geography, 2010 – 2017 ($million)
Table 38 Contrast Media Market Revenue, By Geography,
2010 – 2017 ($million)
Table 39 North America: Contrast Media Market, By Country,
2010 – 2017 ($million)
Table 40 North America: Contrast Media Market, By Product,
2010 – 2017 ($million)
Table 41 North America: Iodinated Contrast Media Market, By Type, 2010 – 2017 ($million)
Table 42 North America: Contrast Media Market, By Application,
2010 – 2017 ($million)
Table 43 North America: Contrast Media Market, By Indication,
2010 – 2017 ($million)
Table 44 North America: Contrast Media Market, By Route Of Administration, 2010 – 2017 ($million)
Table 45 North America: Injectable Contrast Media Market,
By Type, 2010 – 2017 ($million)
Table 46 North America: Contrast Media Market, By Medical Procedure, 2010 – 2017 ($million)
Table 47 Europe: Contrast Media Market, By Country,
2010 – 2017 ($million)
Table 48 Europe: Contrast Media Market, By Product,
2010 – 2017 ($million)
Table 49 Europe: Iodinated Contrast Media Market, By Type,
2010 – 2017 ($million)
Table 50 Europe: Contrast Media Market, By Application,
2010 – 2017 ($million)
Table 51 Europe: Contrast Media Market, By Indication,
2010 – 2017 ($million)
Table 52 Europe: Contrast Media Market, By Route Of Administration, 2010 – 2017 ($million)
Table 53 Europe: Injectable Contrast Media Market, By Type,
2010 – 2017 ($million)
Table 54 Europe: Contrast Media Market, By Medical Procedure,
2010 – 2017 ($million)
Table 55 Apac: Contrast Media Market, By Country,
2010 – 2017 ($million)
Table 56 Apac: Contrast Media Market, By Product,
2010 – 2017 ($million)
Table 57 Apac: Iodinated Contrast Media Market, By Type,
2010 – 2017 ($million)
Table 58 Apac: Contrast Media Market, By Application,
2010 – 2017 ($million)
Table 59 Apac: Contrast Media Market, By Indication,
2010 – 2017 ($million)
Table 60 Apac: Contrast Media Market, By Route Of Administration, 2010 – 2017 ($million)
Table 61 Apac: Injectable Contrast Media Market, By Type,
2010 – 2017 ($million)
Table 62 Apac: Contrast Media Market, By Medical Procedure,
2010 – 2017 ($million)
Table 63 Row: Contrast Media Market Revenue, By Region,
2010 – 2017 ($million)
Table 64 Row: Contrast Media Market Revenue, By Product,
2010 – 2017 ($million)
Table 65 Row: Iodinated Contrast Media Market, By Type,
2010 – 2017 ($million)
Table 66 Row: Contrast Media Market Revenue, By Application,
2010 – 2017 ($million)
Table 67 Row: Contrast Media Market Revenue, By Indication,
2010 – 2017 ($million)
Table 68 Row: Contrast Media Market Revenue, By Route Of Administration, 2010 – 2017 ($million)
Table 69 Row: Injectable Contrast Media Market Revenue, By Type,
2010 – 2017 ($million)
Table 70 Row: Contrast Media Market Revenue, By Medical Procedure,
2010 – 2017 ($million)
Table 71 Mergers & Acquisitions, 2010 – 2012
Table 72 Agreements, Partnerships, Collaborations & Joint Ventures, 2010 – 2012
Table 73 New Product Launch, 2010 – 2012
Table 74 Expansion, 2010 – 2012
Table 75 Approvals, 2010 – 2012
Table 76 Other Developments, 2010 – 2012
Table 77 Amag Pharmaceuticals: Total Revenue And R&D Expenses,
2009 – 2011 ($million)
Table 78 Amag Pharmaceuticals: Total Revenue, By Segment,
2009 – 2011 ($million)
Table 79 Amag Pharmaceuticals: Total Product Sales, By Product, 2009 – 2011 ($million)
Table 80 Bayer Healthcare Pharmaceuticals: Total Revenue And R&D Expenses, 2009 – 2011 ($million)
Table 81 Bayer Healthcare Pharmaceuticals: Total Revenue,
By Segment, 2009 – 2011 ($million)
Table 82 Bayer Healthcare Pharmaceuticals: Total Revenue,
By Geography, 2009 – 2011 ($million)
Table 83 Bayer Healthcare Pharmaceuticals: Total Revenue Of Healthcare Segment, By Division, 2009 – 2011 ($million)
Table 84 Bayer Healthcare Pharmaceuticals: Total Revenue Of Healthcare Segment, By Geography, 2009 – 2011 ($million)
Table 85 Bayer Healthcare Pharmaceuticals: Total Revenue Of Consumer Health Division, By Segment, 2009 - 2011 ($million)
Table 86 Bayer Healthcare Pharmaceuticals: Total Revenue Of Consumer Health Division, By Geography,
2009 – 2011 ($million)
Table 87 Covidien: Net Sales And R&D Expenses, 2009 – 2011 ($million)
Table 88 Covidien: Net Sales, By Segments, 2009 – 2011 ($million)
Table 89 Covidien: Net Sales, By Pharmaceutical Products,
2009 – 2011 ($million)
Table 90 Covidien: Net Sales, By Geography, 2009 – 2011 ($million)
Table 91 Daiichi Sankyo Co., Ltd.: Net Sales And R&D Expenses,
2009 – 2011 ($billion)
Table 92 Daiichi Sankyo Co., Ltd.: Net Sales, By Geography,
2009 – 2011 ($million)
Table 93 General Electric: Total Revenue And R&D Expenses,
2009 – 2011 ($billion)
Table 94 General Electric: Total Revenue, By Segments,
2009 – 2011 ($billion)
Table 95 General Electric: Total Revenue, By Geography,
2009 – 2011 ($billion)
Table 96 Genovis Ab: Total Revenue And R&D Expenses,
2010 – 2012 ($thou.S.Nd)
Table 97 Genovis Ab: Total Revenue, By Geography,
2010 – 2012 ($thou.S.Nd)
Table 98 Guerbet: Total Revenue And R&D Expenses,
2010 – 2012 ($million)
Table 99 Guerbet: Total Revenue, By Products, 2010 – 2012 ($million)
Table 100 Guerbet: Total Revenue, By Geography 2010 – 2012 ($million)
Table 101 Lantheus: Total Revenue And R&D Expenses,
2009 – 2011 ($million)
Table 102 Lantheus: Total Revenue, By Segment, 2009 – 2011 ($million)
Table 103 Lantheus : Total Revenue, By Geography,
2009 – 2011 ($million)
Table 104 Sanochemia Pharmazeutika Ag: Total Revenue And R&D Expenses, 2010 – 2012 ($million)
Table 105 Sanochemia Pharmazeutika Ag: Total Revenue, By Segment, 2010 – 2011 ($million)
Table 106 Sanochemia Pharmazeutika Ag: Total Revenue,
By Geography, 2010 – 2012 ($million)
Table 107 Accelerator Nordic Ab: Total Revenue And R&D Expenses, 2010 – 2012 ($thou.S.Nd)
List Of Figures
Figure 1 Contrast Media Market, By Geography, 2010 – 2017 ($million)
Figure 2 Contrast Media Market Segmentation
Figure 3 Market Dynamics
Figure 4 Global Contrast Media Market Share Analysis,
By Key Players, 2011
Figure 5 Contrast Media Market Segmentation, By Product
Figure 6 Chemistry Of Low Osmolar Contrast Media (Locm)
Figure 7 Chemistry Of High-osmolar Contrast Media (Hocm)
Figure 8 Contrast Media Market Segmentation, By Route Of Administration
Figure 9 Contrast Media Market Segmentation, By Medical Procedure
Figure 10 Contrast Media Market Segmentation, By Indication
Figure 11 Contrast Media Market Segmentation, By Application
Figure 12 Key Growth Strategies, 2010 – 2012
Figure 13 Key Players Focusing On Agreements, Partnerships, Collaborations & Joint Ventures Strategy, 2010 – 2012
Figure 14 Key Players Focusing On New Product Launch Strategy,
2010 – 2012

More Ultrasonography reports by MarketsandMarkets

Pre-Clinical Imaging (In vivo) Market – By Systems and Reagents [Micro-PET, Optical Imaging, Micro-MRI, Micro-SPECT, Micro-Ultrasound, Micro-CT & Multimodality/Hybrid Imaging Modalities] - Competitive Analysis & Global Forecasts to 2017 by MarketsandMarkets
Pre-clinical imaging technologies are excellent tools for assessment of anatomical, physiological and functional parameters at molecular and cellular levels in the live animal models. It ...
Medical Image Analysis Software Market by Types, by Technology, by Image (2D, 3D & 4D) & by Indications - Global Trends, Opportunities & Forecast till 2017 by MarketsandMarkets
The growth of the medical image analysis market is mainly contributed by the standalone software market which is accelerating at a faster pace as compared ...
Ablation Devices Market to 2016 - (Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Cardiac, Cancer and Gynecology) – Global Market Forecast and Trends Analysis by Technology, Devices & Applications by MarketsandMarkets
Ablation procedure refers to a minimally invasive surgical procedure which involves either destruction or removal of diseased or unnecessary tissue to cure the disease. It ...
Medical Diagnostic & Therapeutic Ultrasound Devices Market (2012 - 2017) - Global Trends & Competitive Analysis by MarketsandMarkets
The medical ultrasound devices market consists of devices that involve the projection of cyclic sound waves ranging between 20 KHz – 10 MHz. These waves ...
See all reports like this >>

More Global Ultrasonography reports

Global Markets for Medical Imaging Reagents and Analysis Equipment - Focus on Ultrasound by BCC Research
This report provides: An overview of the imaging, diagnosing and medical markets, with a focus on ultrasound Analyses of global market trends, with data from ...
Medical Ultrasound Devices: Technologies and Global Markets by BCC Research
This report provide: An overview of medical diagnostic acoustic sensors and opportunities in radiology, cardiology, obstetrics/gynecology, surgical, urology, musculoskeletal, and endoscopic Analyses of global market ...
Pre-Clinical Imaging (In vivo) Market – By Systems and Reagents [Micro-PET, Optical Imaging, Micro-MRI, Micro-SPECT, Micro-Ultrasound, Micro-CT & Multimodality/Hybrid Imaging Modalities] - Competitive Analysis & Global Forecasts to 2017 by MarketsandMarkets
Pre-clinical imaging technologies are excellent tools for assessment of anatomical, physiological and functional parameters at molecular and cellular levels in the live animal models. It ...
Analysis of the Diagnostic Imaging Market: Global Trends and Strategies of Key Suppliers by Venture Planning Group
The report provides a worldwide strategic overview of the diagnostic imaging market, including: Estimates of the market size and growth. Sales forecasts by geographic region and modality. Review ...
See all reports like this >>

 

Research assistance

We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 

Related Markets


Ultrasonography Reports

 
 

Share this report


Other tasks

 
 

Join Alert Me now!

Receive bi-weekly email alerts on new market research

Sign up today!